Veralto to Acquire Cleanwater1 for $465M, Expanding Water Treatment Platform
Veralto (VLTO) will acquire Cleanwater1 for $465M, expanding its water treatment portfolio. The deal, expected to close in Q4 2026, adds 25,000 installed units and $135M in annual sales. Veralto values the acquisition at ~17x EBITDA, aiming for modest EPS accretion in 2027 and long-term growth.
How this was made

The 30-second read
Why it matters
The acquisition expands VLTO's product portfolio into chlorine disinfection and odor control, adding a sizable installed base that can generate recurring aftermarket revenue and cross‑selling opportunities with its Trojan UV business.
Market read
The deal is material for VLTO's valuation and may influence the broader water‑treatment sector, offering a catalyst for related stocks.
What to watch
Regulatory approvals and potential antitrust scrutiny could delay closing and affect the deal's timing.
Background
Veralto (NYSE: VLTO) is a diversified water and product quality technology company seeking growth through strategic acquisitions.
Ticker impact
Veralto announced a $465M acquisition of Cleanwater1, expanding its water‑treatment platform and adding a 25,000‑unit installed base.
Potential short‑term upside as investors price in the accretive acquisition and long‑term growth from cross‑selling with Trojan Technologies.
Large‑scale M&A with clear financial terms and synergies; market typically rewards strategic add‑ons that enhance recurring revenue.
Market effects
Strengthens the water‑treatment sector, potentially lifting peers with similar recurring‑revenue models.
May boost investor interest in U.S. industrial and infrastructure stocks focused on municipal water projects.
Highlights continued consolidation in the global water‑quality market, relevant for international water‑tech investors.
Counterpoint
If integration costs exceed expectations, the acquisition could be dilutive, weighing on VLTO's margin outlook.
Key entities
- CompanyVeralto
Acquirer, listed on NYSE under VLTO.
- CompanyCleanwater1
Target, private water‑treatment firm.



